Report Tools

United Therapeutics Corporation - SWOT, Strategy and Corporate Finance Report

Published: July 2013 · Publisher: MarketLine
United Therapeutics Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages56
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6520
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
United Therapeutics Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
- An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for United Therapeutics Corporation
- Intelligence on United Therapeutics Corporationnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

United Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life threatening conditions. The company primarily operates in the US, where it is headquartered in Silver Spring, Maryland. It employed 623 people at the end of February 2013. The company recorded revenues of $916.1 million during the financial year ended December 2012 (FY2012), an increase of 23.3% over FY2011. The operating profit of the company was $421.6 million in FY2012, an increase of 32.7% over FY2011. The net profit was $304.4 million in FY2012, an increase of 39.7% over FY2011.

Reasons to Purchase:

- Gain understanding of United Therapeutics Corporation and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess United Therapeutics Corporation as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on United Therapeutics Corporation’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
United Therapeutics Corporation: Company Overview
United Therapeutics Corporation: Overview and Key Facts
United Therapeutics Corporation: Overview
United Therapeutics Corporation: Key Facts
United Therapeutics Corporation: Key Employees
United Therapeutics Corporation: Key Employee Biographies
United Therapeutics Corporation: Major Products and Services
United Therapeutics Corporation: Company History
United Therapeutics Corporation: Management Statement
United Therapeutics Corporation: Locations and Subsidiaries
United Therapeutics Corporation: Key Competitors
United Therapeutics Corporation: Company Analysis
United Therapeutics Corporation: Business Description
United Therapeutics Corporation: SWOT Analysis
United Therapeutics Corporation: SWOT Overview
United Therapeutics Corporation: Strengths
United Therapeutics Corporation: Weaknesses
United Therapeutics Corporation: Opportunities
United Therapeutics Corporation: Threats
United Therapeutics Corporation: Financial Analysis
United Therapeutics Corporation: Financial Overview
United Therapeutics Corporation: Five Year Company Financials
United Therapeutics Corporation: Key Income Statement Data
United Therapeutics Corporation: Key Balance Sheet Data
United Therapeutics Corporation: Key Cash Flow Data
United Therapeutics Corporation: Key Market Data
United Therapeutics Corporation: Valuation Ratios
United Therapeutics Corporation: Profitability Ratios
United Therapeutics Corporation: Management Efficiency Ratios
United Therapeutics Corporation: Financial Strength Ratios
United Therapeutics Corporation: Operational Efficiency Ratios
United Therapeutics Corporation: Others
United Therapeutics Corporation: Corporate Financial Deals Activity
United Therapeutics Corporation: Financial Deals Overview
United Therapeutics Corporation: Targets and Partners
United Therapeutics Corporation: Top Deals 2009 - 2013YTD*
United Therapeutics Corporation: Advisors
United Therapeutics Corporation: Top Legal Advisors
United Therapeutics Corporation: Mergers and Acquisitions
United Therapeutics Corporation: Capital Raising
United Therapeutics Corporation: Partnership
United Therapeutics Corporation: Divestments
United Therapeutics Corporation: Recent Developments
United Therapeutics Corporation: News and Events Summary
United Therapeutics Corporation: Business Expansion
United Therapeutics Corporation: Contracts
United Therapeutics Corporation: Financial Performance
United Therapeutics Corporation: Regulatory and Legal Events
United Therapeutics Corporation: Research & Development
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: United Therapeutics Corporation: Key Facts
Table 2: United Therapeutics Corporation: Key Employees
Table 4: United Therapeutics Corporation: Key Competitors
Table 5: United Therapeutics Corporation: Key Income Statement Data
Table 6: United Therapeutics Corporation: Key Balance Sheet Data
Table 7: United Therapeutics Corporation: Key Cash Flow Data
Table 8: United Therapeutics Corporation: Key Market Data
Table 9: United Therapeutics Corporation: Key Growth Ratios
Table 10: United Therapeutics Corporation: Valuation Ratios
Table 11: United Therapeutics Corporation: Profitability Ratios
Table 12: United Therapeutics Corporation: Management Efficiency Ratios
Table 13: United Therapeutics Corporation: Financial Strength Ratios
Table 14: United Therapeutics Corporation: Operational Efficiency Ratios
Table 15: United Therapeutics Corporation: Others
Table 16: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 17: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 18: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Table 19: United Therapeutics Corporation: Targets and Partners
Table 20: United Therapeutics Corporation: Top Deals 2009 - 2013YTD*
Table 21: United Therapeutics Corporation: Legal Advisor Ranking by Value (US$m)
Table 22: United Therapeutics Corporation: M&A Volume and Value Trend (2009 - YTD*2013)
Table 23: United Therapeutics Corporation: M&A Activity by Geography (2009 - YTD*2013)
Table 24: United Therapeutics Corporation: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 25: United Therapeutics Corporation: Capital Raising by Deal Type (2009 - YTD*2013)
Table 26: United Therapeutics Corporation: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 27: United Therapeutics Corporation: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 28: United Therapeutics Corporation: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 29: United Therapeutics Corporation: Divestments by Geography (2009 - YTD*2013)
Table 30: United Therapeutics Corporation: News and Events Summary
Table 31: United Therapeutics Corporation: Business Expansion
Table 32: United Therapeutics Corporation: Contracts
Table 33: United Therapeutics Corporation: Financial Performance
Table 34: United Therapeutics Corporation: Regulatory and Legal Events
Table 35: United Therapeutics Corporation: Research & Development

List of Figures

Figure 1: United Therapeutics Corporation: Revenue to Net Income (2007-2011)
Figure 2: United Therapeutics Corporation: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: United Therapeutics Corporation: Current Assets to Current Liabilities (2007-2011)
Figure 4: United Therapeutics Corporation: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: United Therapeutics Corporation: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: United Therapeutics Corporation: Net Change in Cash (2007-2011)
Figure 7: United Therapeutics Corporation: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: United Therapeutics Corporation: Enterprise Value (2007-2011)
Figure 9: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 11: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Figure 12: United Therapeutics Corporation: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 13: United Therapeutics Corporation: M&A Activity by Geography (2009 - YTD*2013)
Figure 14: United Therapeutics Corporation: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 15: United Therapeutics Corporation: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 16: United Therapeutics Corporation: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 17: United Therapeutics Corporation: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 18: United Therapeutics Corporation: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 19: United Therapeutics Corporation: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.